Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Challenges Bcl-2/Apaf-1 binding model; leaves open how prosurvival proteins block caspase activation in vivo.
Moriishi et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: